#news #biotech Versant, Novartis power cystic fibrosis startup Enterprise Therapeutics to series B round

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Versant, Novartis power cystic fibrosis startup Enterprise Therapeutics to series B round .Versant Ventures and Novartis Venture Fund have co-led a £29 million ($41 million) series B round in cystic fibrosis disease startup Enterprise Therapeutics. The financing tees up Enterprise to take three projects into the clinic and push one of them through a midphase proof-of-concept trial. 

from FierceBiotech: Biotech https://ift.tt/2GUaFqi